Pivotal bioVenture Partners

Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies

Business Model: B2B

Revenue: $0

Employees: 0-0

Rankings

Detailed Pivotal bioVenture Partners Information

Geographic Data

Pivotal bioVenture Partners headquarters map

Address: 1700 Owens St Ste 595

City: San Francisco

State: CA

Zip: 94158

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$450M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.

Contact Phone:
+14156971002

Contact Email:

Announced Date Company Transaction Money Raised
5/2021 Oculis Series C 0
4/2019 Fusion Pharmaceuticals Series B 0
3/2019 Karuna Therapeutics Series B 0
7/2020 Bolt Biotherapeutics Series C 93.5M
8/2021 Vigil Neuroscience Series B 0
4/2019 Inozyme Series A 67.4M
3/2017 Vaxcyte Series B 60M
3/2020 Vaxcyte Series D 0
5/2017 Iterum Therapeutics Series B 65M
4/2020 Avalyn Pharma Series B 35.5M
9/2017 Entasis Therapeutics Series B 31.9M
10/2019 Arcutis Biotherapeutics Series C 94.5M
9/2021 Obsidian Therapeutics Series B 0
11/2022 Zenas BioPharma Series B 0
3/2020 Akouos Series B 105M
4/2021 Exscientia Series D 225M
1/2020 Aligos Therapeutics Series B 125M
9/2021 Evommune Series A 83M
4/2023 Evommune Series B 50M
2/2022 Plexium Series B 0
11/2021 HotSpot Therapeutics Series C 0
2/2022 Arkuda Therapeutics Series B 0
2/2019 Bolt Series B 54M
11/2021 SanReno Therapeutics Funding Round 0
6/2018 Stealth BioTherapeutics Convertible Note 0
11/2020 Evommune Seed Round 12.5M
1/2021 Plexium Series A 35M
4/2020 Rallybio Series B 0
3/2023 Oculis Post-IPO Equity 0
1/2018 Oculis Series B 20.5M
2/2022 Plexium Series B 0
2/2022 Arkuda Therapeutics Series B 0
11/2021 SanReno Therapeutics Funding Round 0
11/2021 HotSpot Therapeutics Series C 0
9/2021 Obsidian Therapeutics Series B 0
9/2021 Evommune Series A 0
8/2021 Vigil Neuroscience Series B 0
5/2021 Oculis Series C 0
4/2021 Exscientia Series D 0
1/2021 Plexium Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research